Question 1

What is the catalog number for 6-bromo-2,4-dichloro-5H-pyrrolo[3,2-d]pyrimidine?

Accepted Answer

The catalog number for 6-bromo-2,4-dichloro-5H-pyrrolo[3,2-d]pyrimidine is LCC27525.

Question 2

What sizes are available for 6-bromo-2,4-dichloro-5H-pyrrolo[3,2-d]pyrimidine?

Accepted Answer

6-bromo-2,4-dichloro-5H-pyrrolo[3,2-d]pyrimidine is available in the following size(s): 50 mg, 0.5 g.

Question 3

How many pack sizes does 6-bromo-2,4-dichloro-5H-pyrrolo[3,2-d]pyrimidine come in?

Accepted Answer

6-bromo-2,4-dichloro-5H-pyrrolo[3,2-d]pyrimidine is available in 2 different pack sizes.

Question 4

Is 6-bromo-2,4-dichloro-5H-pyrrolo[3,2-d]pyrimidine in stock?

Accepted Answer

6-bromo-2,4-dichloro-5H-pyrrolo[3,2-d]pyrimidine is currently made to order / not held in immediate stock. Contact us for lead time.

Question 5

What applications has this product been validated for?

Accepted Answer

Validated applications such as WB, ELISA, IHC, ICC, or FC are listed on the product datasheet. If you need application-specific validation data before ordering, contact our technical support team with the catalogue number.

Question 6

How do I reconstitute this lyophilized product?

Accepted Answer

Reconstitution instructions, including the recommended diluent and final concentration, are provided on the datasheet. Aliquot immediately after reconstitution to avoid repeated freeze-thaw cycles.

Question 7

What is the recommended incubation time for this antibody?

Accepted Answer

A suggested incubation time is provided in the recommended protocol on the datasheet, but may need adjusting depending on your sample type and detection system.

6-bromo-2,4-dichloro-5H-pyrrolo[3,2-d]pyrimidine

Product Specifications

CAS Number

MDL Number

Smiles

Molecular Formula

Molecular Weight

Controlled

Available Sizes

Frequently Asked Questions

Explore Other Products

Pmel17 / gp100 / SILV (NKI-beteb), CF594 conjugate, 0.1mg/mL

Complement C4d (C4D204), CF640R conjugate, 0.1mg/mL

CD59 (heavy chain of Protectin) (BRA-10G), CF647 conjugate, 0.1mg/mL

CD53 (161-2), CF647 conjugate, 0.1mg/mL

CD104 (UM-A9), CF488A conjugate, 0.1mg/mL

PD-L1 / PDCD1LG1 / CD274 / B7-H1 (Cancer Immunotherapy Target) (PDL1/2746), CF568 conjugate, 0.1mg/mL